Study to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal Cancer (FOSCO)
This study has been terminated.
Study NCT00889343
Information provided by AIO-Studien-gGmbH
First Received on April 17, 2009.
Last Updated on March 1, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
